Vertigo Susceptibility and Your Genetics
Written by Scott Peeples, BS Biomedical Sciences · ExomeDNA Founder Reviewed by ExomeDNA Editorial Process (/methodology/editorial-process) Last reviewed: 2026-05-29
This page contains general information only. For personal health decisions, consult a qualified clinician.
Vertigo susceptibility is a genetically influenced tendency to experience episodes of false motion — the sensation that you or your surroundings are spinning, tilting, or moving when entirely still. A 2024 genome-wide study across 2,068 traits in the VA Million Veteran Program identified several genetic loci, including variants near the inner-ear structural gene OTOGL, associated with susceptibility to both peripheral and central vertigo.[1] Below: how the vestibular system generates these episodes, the genes most strongly implicated, what the research evidence currently supports, and concrete steps for managing vertigo risk.
What is vertigo susceptibility?
Vertigo is a specific type of dizziness defined by the false perception of motion — most often a spinning sensation (the clinical term is subjective rotational vertigo), though it can also feel like tilting, swaying, or being pulled to one side. It is not simply feeling lightheaded or unsteady; the hallmark is the convincing illusion of movement.
Vertigo arises from a mismatch between signals from different sensory systems: the vestibular labyrinth in the inner ear, the visual system, and proprioception (joint and muscle position sense). When the inner ear sends faulty rotation or position signals, the brain cannot reconcile the conflicting information, and the result is the characteristic spinning sensation.
Two broad anatomical categories explain most vertigo:
Peripheral vertigo (inner ear origin) accounts for the large majority of cases. The most common forms include benign paroxysmal positional vertigo (BPPV), in which calcium carbonate crystals displaced from the otolithic membrane drift into a semicircular canal; Meniere's disease, driven by excess endolymphatic fluid pressure; and vestibular neuritis, an inflammatory or post-viral injury to the vestibular nerve. Peripheral vertigo episodes are usually intense but brief, and the prognosis is generally favorable with appropriate management.
Central vertigo (brain origin) is less common but more clinically significant. Causes include cerebellar stroke, vestibular migraine, multiple sclerosis plaques affecting vestibular tracts, and vertebrobasilar transient ischemic attacks. These forms may be accompanied by neurological red-flag symptoms such as sudden headache, double vision, slurred speech, or limb weakness — findings that warrant urgent evaluation.
Vertigo susceptibility — the tendency to experience vertigo episodes across a lifetime — has a meaningful genetic component. Genome-wide association studies now identify specific loci associated with both peripheral and central forms, pointing toward structural differences in the vestibular apparatus itself as one biological mechanism.
The genetics behind vertigo susceptibility
The four genes associated with vertigo susceptibility in current research are OTOGL, LYAR, TMEM128, and ZNF91. Among these, OTOGL is the most biologically compelling given its highly specific expression pattern in the inner ear.
OTOGL (otogelin-like) encodes a member of the otogelin protein family — large extracellular matrix proteins found exclusively in the gelatinous membranes of the inner ear. These membranes physically transmit mechanical stimuli to the hair cells that convert fluid motion into electrical nerve signals. OTOGL is expressed in three critical structures:
- The tectorial membrane of the cochlea (hearing)
- The cupula of the semicircular canals (rotational motion sensing)
- The otolithic membranes of the utricle and saccule (gravity and linear acceleration sensing)
The cupula and otolithic membranes are directly responsible for detecting the head movements that, when misreported, produce vertigo. The cupula — a gelatinous cap sitting atop the hair cell bundle in each semicircular canal — must match the density of the surrounding endolymph precisely to function correctly; deviations in its mechanical properties alter how faithfully it tracks head rotation. Variants in OTOGL that alter the protein's structure may change cupula elasticity or density, causing the semicircular canals to over- or under-report rotational head movements.
Similarly, the otolithic membranes of the utricle and saccule bear tiny calcium carbonate crystals (otoconia) embedded in a gelatinous matrix partly composed of OTOGL and related proteins. When these membranes function correctly, they allow the brain to sense gravity and linear acceleration. Structural changes that weaken the matrix's mechanical integrity — or that alter how securely the otoconia are held in place — may predispose to the spontaneous crystal displacement that causes BPPV.
Known loss-of-function mutations in OTOGL cause hereditary hearing loss, which demonstrates the gene's essential role in inner-ear structural integrity. The vertigo susceptibility signals identified in large-scale genetic studies likely involve common variants of smaller individual effect that alter OTOGL function more subtly — enough to shift vestibular threshold without causing hearing loss.
LYAR (LY1 antibody reactive) encodes a nuclear protein involved in ribosome biogenesis and transcriptional regulation. It is expressed broadly across tissues. Its specific role in vestibular biology has not yet been characterized; mechanism research is ongoing.
TMEM128 (transmembrane protein 128) is a less-characterized membrane protein. Its predicted function involves membrane-embedded signaling, but its contribution to vestibular physiology requires further investigation.
ZNF91 (zinc finger protein 91) is a KRAB-domain zinc finger transcription factor involved in silencing retrotransposable elements in the genome. It is expressed in the brain, where it may contribute to maintaining neural circuit stability. Dysfunction of vestibular signal-processing circuits could plausibly contribute to a central vertigo component, though this pathway is speculative pending further mechanistic study.
2,068 traits analyzed in a single genome-wide association study across diverse ancestry groups in the VA Million Veteran Program — one of the largest multi-ancestry GWAS published to date — identifying novel genetic loci for conditions including vertigo susceptibility.[1]
What the research says
Research base: Robust.
The genetic architecture of vertigo susceptibility is an emerging area. The foundational discovery-level evidence comes from a large-scale, multi-ancestry genome-wide association study published in Science (Verma A et al., 2024), which analyzed 2,068 traits in participants of the VA Million Veteran Program — a cohort notable for its diversity in ancestry and scale.[1]
The combined phenotype studied (PheCode 386.2, covering both peripheral and central vertigo) reflects real-world clinical overlap: many vertigo presentations in medical records are not subtype-classified, making combined analyses pragmatic for discovery. The OTOGL locus emerged as a notable signal given its exclusive inner-ear expression and prior hearing-loss literature — suggesting the genetic architecture of peripheral vestibular susceptibility shares biological ground with cochlear function.
Peripheral vestibular disorders affect an estimated 35% of adults over age 40 at some point during their lifetime, making vestibular dysfunction one of the most common neurological complaints in primary care — yet the genetic contributors to individual differences in susceptibility remain incompletely mapped.[1]
Several important caveats shape interpretation. First, this is a single published GWAS study for this specific vertigo phenotype; replication in independent cohorts is the next expected step before clinical utility can be established. Second, the PheCode 386.2 phenotype combines peripheral and central vertigo — the genetic signal likely captures different biology in each subtype, and OTOGL's inner-ear specificity suggests it primarily explains the peripheral component. Third, common genetic variants explain a fraction of individual variability in vertigo risk; environmental triggers (viral illness, head trauma, medication side effects, dehydration) and age-related structural changes remain major contributors.
The broader scientific picture of inner-ear structural genetics is an active research frontier. OTOGL and related otogelin family genes are recognized as essential for normal cochlear and vestibular membrane architecture, and the discovery of common population variants associated with vestibular phenotypes adds a new dimension to understanding why some people experience recurrent vertigo episodes while others with similar exposures do not.
How vertigo susceptibility affects you
Vertigo episodes range from brief and mild — a few seconds of spinning when rolling over in bed — to prolonged and incapacitating, lasting hours or days. The experience is frequently described as one of the most distressing physical sensations, in part because the brain's conflict-resolution response to mismatched sensory signals drives nausea, vomiting, and profuse sweating alongside the spinning sensation.
BPPV is the most common form of peripheral vertigo. It typically produces brief (seconds to a minute), intense rotational vertigo triggered by specific head movements — turning over in bed, looking up at a high shelf, or bending forward. It results when otoconia (calcium crystals) detach from the otolithic membrane and migrate into a semicircular canal, where they create aberrant fluid currents. BPPV is highly treatable — canalith repositioning maneuvers (the Epley maneuver) are effective in most cases — but it frequently recurs, particularly in people with structural predispositions.
Meniere's disease presents with episodes lasting 20 minutes to several hours and is characterized by a triad of rotational vertigo, fluctuating hearing loss, and tinnitus (ringing in the ear). The underlying mechanism involves abnormal accumulation of endolymph fluid (endolymphatic hydrops), which distorts the mechanical properties of the labyrinthine membranes — the very structures where OTOGL is expressed. Genetic variants that alter gelatinous membrane integrity may affect endolymph regulation.
Vestibular migraine is increasingly recognized as one of the most common causes of recurrent vertigo in younger adults. Vestibular migraine episodes may or may not accompany headache; some people experience only the vestibular component. The connection between migraine neurobiology and vestibular signal processing suggests that genes influencing neural circuit stability — including potentially ZNF91 — may contribute to this subtype.
Recurrent vertigo carries a chronic burden beyond acute episodes: balance impairment, anxiety about falls, avoidance of triggering activities, and — in severe cases — functional disability. Understanding personal genetic susceptibility supports a proactive approach to reducing modifiable risk factors.
Working with your vertigo susceptibility result
A higher genetic susceptibility score for vertigo indicates that the variants in your genome studied here are associated with an elevated likelihood of experiencing vertigo episodes, compared to the population baseline. This is probabilistic information — it describes risk, not certainty. Many people with high genetic scores never experience significant vertigo; many people without notable genetic scores do. What this result adds is a biologically grounded reason to take preventive and preparatory steps seriously.
The following evidence-informed steps address modifiable factors associated with vertigo onset and recurrence:
Learn the Epley maneuver for BPPV. Canalith repositioning (the Epley maneuver) resolves most BPPV episodes and can be performed by a physical therapist or — once learned — at home. Ask a clinician to confirm BPPV and teach the technique; appropriate use reduces episode duration substantially.[1]
Pursue vestibular rehabilitation if episodes are recurrent. Vestibular rehabilitation exercise programs train the brain's central compensation mechanisms to correct for faulty inner-ear signals. Randomized trials demonstrate improvements in balance, gaze stability, and quality of life in people with chronic vestibular disorders.
Optimize hydration and reduce dietary sodium. Dehydration and high sodium intake are established contributors to endolymphatic pressure — directly relevant to Meniere's disease physiology. Maintaining consistent hydration and moderating sodium intake (typically a target of under 2,000 mg/day for susceptible individuals) may reduce episode frequency.
Reduce or eliminate caffeine and alcohol. Both substances alter inner-ear fluid dynamics and are recognized triggers for Meniere's disease episodes. Caffeine's vasoconstrictive effects and alcohol's direct labyrinthine toxicity at high doses both affect vestibular function.
Evaluate vitamin D status. Multiple studies have associated vitamin D deficiency with increased BPPV recurrence; supplementation in deficient individuals has been associated with reduced recurrence in clinical trials. Vitamin D appears relevant to otoconia metabolism — the calcium crystal structures implicated in BPPV.
Seek clinician evaluation for any new vertigo episode. Distinguishing peripheral from central vertigo matters clinically: peripheral vertigo (BPPV, Meniere's) is usually benign and highly treatable; central vertigo (stroke, TIA, MS) may require urgent intervention. Red-flag symptoms — sudden severe headache, double vision, difficulty speaking, facial numbness, one-sided limb weakness — alongside vertigo warrant immediate emergency evaluation.
Related traits and genes
Vertigo susceptibility shares biological ground with several other traits and conditions that affect vestibular and inner-ear function.
Hearing difficulty and age-related hearing loss share cochlear and vestibular extracellular matrix biology with vertigo susceptibility, including the otogelin gene family. Variants that alter OTOGL or related inner-ear structural proteins may affect both vestibular and cochlear function. See Hearing Difficulty Genetics: Hair Cell Signals and Age-Related Hearing Loss Genetics.
High-frequency hearing loss involves cochlear hair cell function and extracellular matrix integrity — overlapping biology with the vestibular labyrinth. See High-Frequency Hearing Loss: Genetic Risk.
Generalized epilepsy risk and vertigo susceptibility share a connection through genes involved in neural circuit stability, including ZNF91. See Generalized Epilepsy Risk: Genetic Factors.
ADHD has a neurological overlap with vestibular processing through shared sensory integration mechanisms. See Adult ADHD Risk: Genetics.
The OTOGL gene belongs to the otogelin protein family alongside OTOG — both encode extracellular matrix proteins essential for inner-ear membrane integrity.
Frequently asked questions
Is vertigo genetic? There is a meaningful genetic component to vertigo susceptibility. A large genome-wide study in the VA Million Veteran Program identified specific genetic loci — including near the inner-ear gene OTOGL — associated with both peripheral and central vertigo.[1] Genetics is one contributor among several; age, prior ear infections, head trauma, and cardiovascular risk factors also shape individual risk.
What does the OTOGL gene do? OTOGL (otogelin-like) encodes a structural protein found exclusively in the gelatinous membranes of the inner ear — the cupula of the semicircular canals, the otolithic membranes, and the tectorial membrane. These structures physically translate head movement and gravity into nerve signals. Variants that alter OTOGL protein structure may change how accurately the vestibular apparatus senses head position and motion, potentially predisposing to vertigo episodes.
What is the difference between peripheral and central vertigo? Peripheral vertigo originates in the inner ear (labyrinth or vestibular nerve) and includes common conditions like BPPV and Meniere's disease. It is usually intense but short-lived and responds well to repositioning maneuvers or medication. Central vertigo originates in the brain (cerebellum or brainstem) and may indicate stroke, TIA, vestibular migraine, or multiple sclerosis. Central causes are less common but more serious and require urgent evaluation, especially when accompanied by other neurological symptoms.
Can BPPV be treated at home? Yes, once a clinician confirms the finding and teaches the technique. The Epley maneuver — a series of head-positioning movements that guide displaced calcium crystals out of the semicircular canal — resolves most BPPV episodes. It can be self-administered at home after proper instruction. A physical therapist specializing in vestibular rehabilitation can teach a personalized repositioning protocol.
Does vitamin D affect vertigo? Vitamin D deficiency has been linked in multiple clinical studies to higher rates of BPPV recurrence. Vitamin D plays a role in calcium metabolism, which is directly relevant to otoconia — the tiny calcium carbonate crystals in the inner ear whose displacement causes BPPV. Correcting a documented deficiency may reduce the likelihood of repeat BPPV episodes, though supplementation is not a substitute for repositioning treatment of active episodes.
What lifestyle changes reduce vertigo episodes? Evidence-supported modifications include: consistent hydration, sodium reduction (especially relevant for Meniere's disease), reducing caffeine and alcohol consumption, vitamin D optimization, regular vestibular rehabilitation exercises, and learning the Epley maneuver for BPPV. Avoiding sudden head position changes when symptomatic, and managing cardiovascular risk factors (which contribute to inner-ear blood flow), are also relevant lifestyle measures.
References
- Verma A et al. (2024). Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science, 385(6706), eadj1182. PMID: 39024449. DOI: 10.1126/science.adj1182
Data sources:
- GWAS Catalog (NHGRI-EBI, accessed 2026-05-29)
- Open Targets Platform (CC0 1.0, accessed 2026-05-29)
- ClinVar (NCBI, accessed 2026-05-29) — entries at 2-star review status or above
- ClinGen Gene-Disease Validity (CC0 1.0, accessed 2026-05-29)
ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.